U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Unresectable Primary Peritoneal Serous Adenocarcinoma

MedGen UID:
1734386
•Concept ID:
C5418958
•
Neoplastic Process

Definition

Primary peritoneal serous adenocarcinoma that is not amenable to surgical resection. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVUnresectable Primary Peritoneal Serous Adenocarcinoma

Recent clinical studies

Etiology

Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness.
da Costa Miranda V, de Souza Fêde ÂB, Dos Anjos CH, da Silva JR, Sanchez FB, da Silva Bessa LR, de Paula Carvalho J, Filho EA, de Freitas D, Del Pilar Estevez Diz M
Gynecol Oncol 2014 Feb;132(2):287-91. Epub 2013 Dec 9 doi: 10.1016/j.ygyno.2013.12.002. PMID: 24333355
Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE, Montz FJ, Lagasse LD, Leuchter RS, Karlan BY
Gynecol Oncol 1999 Mar;72(3):278-87. doi: 10.1006/gyno.1998.5145. PMID: 10053096

Diagnosis

Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness.
da Costa Miranda V, de Souza Fêde ÂB, Dos Anjos CH, da Silva JR, Sanchez FB, da Silva Bessa LR, de Paula Carvalho J, Filho EA, de Freitas D, Del Pilar Estevez Diz M
Gynecol Oncol 2014 Feb;132(2):287-91. Epub 2013 Dec 9 doi: 10.1016/j.ygyno.2013.12.002. PMID: 24333355
Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE, Montz FJ, Lagasse LD, Leuchter RS, Karlan BY
Gynecol Oncol 1999 Mar;72(3):278-87. doi: 10.1006/gyno.1998.5145. PMID: 10053096

Therapy

Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness.
da Costa Miranda V, de Souza Fêde ÂB, Dos Anjos CH, da Silva JR, Sanchez FB, da Silva Bessa LR, de Paula Carvalho J, Filho EA, de Freitas D, Del Pilar Estevez Diz M
Gynecol Oncol 2014 Feb;132(2):287-91. Epub 2013 Dec 9 doi: 10.1016/j.ygyno.2013.12.002. PMID: 24333355

Prognosis

Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE, Montz FJ, Lagasse LD, Leuchter RS, Karlan BY
Gynecol Oncol 1999 Mar;72(3):278-87. doi: 10.1006/gyno.1998.5145. PMID: 10053096

Clinical prediction guides

Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness.
da Costa Miranda V, de Souza Fêde ÂB, Dos Anjos CH, da Silva JR, Sanchez FB, da Silva Bessa LR, de Paula Carvalho J, Filho EA, de Freitas D, Del Pilar Estevez Diz M
Gynecol Oncol 2014 Feb;132(2):287-91. Epub 2013 Dec 9 doi: 10.1016/j.ygyno.2013.12.002. PMID: 24333355
Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE, Montz FJ, Lagasse LD, Leuchter RS, Karlan BY
Gynecol Oncol 1999 Mar;72(3):278-87. doi: 10.1006/gyno.1998.5145. PMID: 10053096

Supplemental Content

Table of contents

    Practice guidelines

    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...